Fungal rhinosinusitis: diagnosis and therapy

M S Schubert1

  • 1Allergy Asthma Clinic, Ltd, 31 W Camelback Road, Phoenix, AZ 85013, USA.

Insights

Allergic fungal sinusitis (AFS) is the most common fungal rhinosinusitis. Diagnosis involves histopathology, and treatment requires surgery with medical management, though recurrence rates remain high.

Area of Science:

  • Otolaryngology
  • Allergy and Immunology
  • Mycology

Background:

  • Fungal rhinosinusitis encompasses five clinicopathologic forms: invasive (acute fulminant, chronic, granulomatous) and noninvasive (fungal ball, allergic fungal sinusitis - AFS).
  • Allergic fungal sinusitis (AFS) is the most prevalent form, affecting immunocompetent, atopic individuals with chronic rhinosinusitis and nasal polyps.
  • Clinical presentation may include nasal casts and proptosis due to orbital extension.

Purpose of the Study:

  • To delineate the clinicopathologic characteristics, diagnostic criteria, treatment strategies, and prognostic factors of fungal rhinosinusitis, with a focus on AFS.

Main Methods:

  • Diagnosis relies on surgical histopathology, identifying extramucosal allergic mucin with fungal hyphae and eosinophilic-lymphocytic inflammation, often supplemented by fungal cultures.
  • Sinus CT imaging reveals mucosal hypertrophy and sinus content hyperattenuation.

Main Results:

  • Bipolaris spicifera is the most frequently cultured fungus in AFS.
  • The immunopathology of AFS mirrors that of allergic bronchopulmonary aspergillosis.
  • Histopathology confirms allergic mucin with scattered fungal elements and inflammatory infiltrates.

Conclusions:

  • Effective treatment for AFS necessitates surgical intervention combined with aggressive postoperative medical management, including allergy medications, immunotherapy, and potentially oral corticosteroids.
  • Despite improved outcomes with medical management, high recurrence rates underscore the need for further research and optimized treatment protocols.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...